Several anti-human immunodeficiency virus type 1 reverse transcriptase inhibitors were evaluated for their antiviral activities against porcine endogenous retrovirus in human cells. Among the test compounds, zidovudine was found to be the most active. The order of potency was zidovudine > phosphonylmethoxyethoxydiaminopyrimidine ؍ phosphonylmethoxypropyldiaminopurine > tenofovir > adefovir > stavudine.Xenotransplantation, the grafting of cells, tissues, or organs into different species, may be one of the solutions to overcome the extreme shortage of human allografts for transplantation (3). Pigs are considered to be the most suitable donors because of the resemblance of their organ sizes and functions to those of humans. However, there are two major obstacles to successful xenotransplantation, namely, immunological rejection and a risk of zoonosis. Recently, porcine endogenous retrovirus (PERV) has attracted much attention due to its omnipresent nature in pigs and vertical transmission in the host DNA. PERV is a type C retrovirus that is permanently integrated into the host genomic DNA as a provirus. Multiple copies of PERV proviral DNA exist in all of the breeds examined to date. PERV comprises three subtypes, PERV-A, -B, and -C, based on the divergence of their envelope genes, whereas their protease and reverse transcriptase (RT) sequences are highly conserved. PERV particles released from a variety of porcine cells have been shown to infect a certain range of human cell lines in vitro (14,18,27). Fortunately, PERV infection in vivo has not been demonstrated in retrospective surveys of the patients who received living porcine tissues, such as liver, kidney, and islet cells (8,16,17). However, Paradis and colleagues reported that long-lived microchimerism was found in some patients treated by extracorporeal splenic perfusion, which might increase a potential risk of PERV infection through its activation (16). Thus, it seems premature to exclude the possibility of PERV transmission from donor organs to recipients upon xenotransplantation. Furthermore, it is also possible that recombination between PERV and human endogenous retrovirus generates novel retroviruses pathogenic to humans (23).Were PERV infection in humans to occur and subsequently develop into disease, antiviral chemotherapy would be the first option for the prophylaxis and treatment of the infection. Among anti-human immunodeficiency virus type 1 (HIV-1) drugs, nucleoside/nucleotide RT inhibitors (NRTIs) are the most likely to block the replication of retroviruses other than HIV-1. In fact, murine leukemia virus replication was examined in human cells and found to be susceptible to some antiviral drugs licensed for the treatment of HIV-1 infection (20). Similar studies with NRTIs were also conducted for PERV replication, and zidovudine (AZT) and didanosine proved to be potent and selective inhibitors (21,22). Considering the fact that the acyclic nucleoside phosphonate tenofovir (PMPA) is highly effective in the treatment of HIV-1 infection and is...